Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Summary by Hastings Tribune
– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 –

21 Articles

Hastings TribuneHastings Tribune
Center

Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights

– Submitted Investigational New Drug (IND) application to evaluate SL-325 in a Phase 1 clinical trial in healthy volunteers; clearance expected in Q3 2025 –

Read Full Article
Aspen Daily NewsAspen Daily News
+19 Reposted by 19 other sources
Center

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results

PALO ALTO, Calif., Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 78% of the sources are Center
78% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Missoulian broke the news in Missoula, United States on Wednesday, August 13, 2025.
Sources are mostly out of (0)

Similar News Topics

Influenza icon

Influenza

Palo Alto icon

Palo Alto

News
For You
SearchBlindspotLocal